Identification and Management of Tardive Dyskinesia
b'Guest: Amber Hoberg, PMHNP
\\n\\n Guest: Jonathan M. Meyer, MD
\\n\\n\\n \\n
Tardive dyskinesia (TD) can be observed in patients receiving long-term treatment with dopamine receptor blocking agents. As the indications for these agents have expanded, TD is becoming more prevalent. In this activity, an expert reviews TD including risk factors, prevention, and treatment.
'